O4‐11‐02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases. (1st July 2015) - Vanderstichele, Hugo Marcel; Stephenson, Diane; Shaw, Leslie M.; Carrillo, Maria; Umek, Robert; Rajapakse, Hemaka; Luthman, Johan; Soares, Holly; Gordon, Mark Forrest; Devanarayan, Viswanath; Genius, Just; Berman, Robert; et al.